{"parse":{"title":"Hepatitis B in China","pageid":6127515,"revid":846584823,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Hepatitis_B_in_China&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(January 2009)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b><a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">Hepatitis B</a></b> is <a href=\"/wiki/Endemic_(epidemiology)\" title=\"Endemic (epidemiology)\">endemic</a> <b>in <a href=\"/wiki/China\" title=\"China\">China</a></b>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> Of the 350 million individuals worldwide infected with the <a href=\"/wiki/Hepatitis_B_virus\" title=\"Hepatitis B virus\">hepatitis B virus</a> (HBV), one-third reside in China.<sup id=\"cite_ref-pmid15602165_2-0\" class=\"reference\"><a href=\"#cite_note-pmid15602165-2\">&#91;2&#93;</a></sup> As of 2006 China has immunized 11.1 million children in its poorest provinces as part of several programs initiated by the Chinese government and as part of the <a href=\"/wiki/GAVI_Alliance\" class=\"mw-redirect\" title=\"GAVI Alliance\">Global Alliance for Vaccines and Immunization</a> (GAVI).  However, the effects of these programs have yet to reach levels of immunization that would limit the spread of hepatitis B effectively.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Epidemiology</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Prevalence\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Prevalence</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Transmission\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Transmission</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Programs\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Programs</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Public_awareness\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Public awareness</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Vaccination\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Vaccination</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Treatment\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Treatment</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Governmental_intervention\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Governmental intervention</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Problems\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Problems</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Research\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Research</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Progress\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Progress</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Social_impact\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Social impact</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Discrimination\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Discrimination</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#&quot;In_the_Hepatitis_B_Camp&quot;\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">\"In the Hepatitis B Camp\"</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=1\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Prevalence\">Prevalence</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=2\" title=\"Edit section: Prevalence\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Of the 350 million to 400 million individuals worldwide infected with the <a href=\"/wiki/Hepatitis_B_virus\" title=\"Hepatitis B virus\">hepatitis B virus</a> (HBV), one-third reside in China, with 130 million carriers and 30 million chronically infected.<sup id=\"cite_ref-pmid15602165_2-1\" class=\"reference\"><a href=\"#cite_note-pmid15602165-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> Since the Expanded Program on Immunization (EPI) beginning 1992, the prevalence of HBV has declined, especially among children 3 to 12 years old.<sup id=\"cite_ref-pmid16471211_4-0\" class=\"reference\"><a href=\"#cite_note-pmid16471211-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> During a 5-year period, 10.0% of patients with chronic hepatitis developed <a href=\"/wiki/Cirrhosis\" title=\"Cirrhosis\">cirrhosis</a>, and 20.3% of the cases with compensated cirrhosis progressed to decompensated cirrhosis. 6.5% of the people with cirrhosis and chronic hepatitis progressed to <a href=\"/wiki/Hepatocellular_carcinoma\" title=\"Hepatocellular carcinoma\">hepatocellular carcinoma</a> (HCC). 5-year survival for compensated cirrhosis is 55%, that for decompensated cirrhosis is 14%, and that for HCC is less than 5%.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> Every year, 300,000 people die from HBV-related diseases in China, including 180,000 patients with HCC.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> However, the incidence of hepatitis B is still increasing, from 21.9 in 100,000 people in 1990 to 53.3 in 100,000 in 2003.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> That increase has occurred despite a <a href=\"/wiki/Vaccination\" title=\"Vaccination\">vaccination</a> program for newborn babies since the 1990s, which showed good effectiveness for reducing chronic HBV infection in children.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Transmission\">Transmission</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=3\" title=\"Edit section: Transmission\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The reason for this increased HBV infection is unknown, because hepatitis B has no clear transmission routes in many people in China, although both <a href=\"/wiki/Neonatal\" class=\"mw-redirect\" title=\"Neonatal\">neonatal</a> <a href=\"/wiki/Infection\" title=\"Infection\">infection</a> and <a href=\"/wiki/Horizontal_transmission\" title=\"Horizontal transmission\">horizontal transmission</a> during early childhood are still the most common routes. During and before the Cultural revolution many of the cases came from re-used needles that were contaminated with HBV.\n</p>\n<h2><span class=\"mw-headline\" id=\"Programs\">Programs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=4\" title=\"Edit section: Programs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Public_awareness\">Public awareness</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=5\" title=\"Edit section: Public awareness\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Public awareness of the disease, which is spread through the exchange of bodily fluids, is not as high as it is for <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a> and <a href=\"/wiki/AIDS\" class=\"mw-redirect\" title=\"AIDS\">AIDS</a>. In some rural areas, doctors have <a href=\"/wiki/Needle_sharing\" title=\"Needle sharing\">reused</a> <a href=\"/wiki/Syringes\" class=\"mw-redirect\" title=\"Syringes\">syringes</a> and unknowingly spread the disease, particularly among <a href=\"/wiki/Pediatrics\" title=\"Pediatrics\">children</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Vaccination\">Vaccination</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=6\" title=\"Edit section: Vaccination\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>By 2006, China has successfully immunised 11.1 million children living in the country's poorest provinces against hepatitis B according to the Chinese health ministry, and the <a href=\"/wiki/Global_Alliance_for_Vaccines_and_Immunization\" class=\"mw-redirect\" title=\"Global Alliance for Vaccines and Immunization\">Global Alliance for Vaccines and Immunization</a> (GAVI). However, China still has a long way to go before immunisation levels reach a percentage able to limit the spread of hepatitis B. China's health minister, <a href=\"/wiki/Gao_Qiang\" title=\"Gao Qiang\">Gao Qiang</a> told a Beijing press conference that the project, while effective, has covered only one third of all children born in China since the project began in 2002. This does not mean the rest of China's children went unvaccinated. However, even within the project's target area, over one million newborns went unvaccinated each year because of access issues; health-care costs, lack of birth attendants, and the remoteness of their birthplaces, such as herder's huts, mountain villages, and remote farms.\n</p><p>Until 2005, when a law banning the practice was passed, parents were charged fees for the administration of the vaccine. Even though the GAVI alliance (whose partners include <a href=\"/wiki/UNICEF\" title=\"UNICEF\">UNICEF</a> and the <a href=\"/wiki/WHO\" class=\"mw-redirect\" title=\"WHO\">WHO</a>), and Chinese government were providing the vaccine and one-use needles free of charge, health-care workers charged fees that parents were unwilling or unable to pay.\n</p><p>Based on a 1992 epidemiological survey, the disease burden of those who are chronically infected with hepatitis B in China is estimated to be at 120 million, one third of the overall burden (360 million) as estimated by the WHO.\n</p><p>China's national target is to reach greater than 85% vaccination. The joint project with the GAVI alliance has shown that this is feasible with three quarters of the 1301 project counties reporting that 85% or more children received three doses of HepB vaccine. In hospitals designated as project hospitals, the percentage of newborns vaccinated within 24 hours of birth is now over 90%. However, the overall newborn vaccination rate in the region covered by the GAVI alliance/government joint project was 70%, lower than the 75% they hoped to achieve.\n</p><p>Achieving long-term success will require \"assuring no new financial barriers arise\", said Julian Lob-Levyt, Executive Secretary of the GAVI Alliance. \"This is one of the greatest challenges and the solution lies not just within China but with a global community mobilized to ensure access to vaccine financing for all <a href=\"/wiki/Developing_nations\" class=\"mw-redirect\" title=\"Developing nations\">developing nations</a>.\"\n</p><p>Home to a large population of ethnic minorities of low socioeconomic status, the Qinghai province is a remote, often neglected, rural region of China with a high prevalence of chronic hepatitis B.  Since many children 5 years of age and older in Qinghai were not vaccinated against the hepatitis B virus at birth, a private-public partnership was formed between the Ping and Amy Chao Foundation, the ZeShan Foundation, the Asian Liver Center at Stanford University, the China Center for Disease Control and Prevention, the Chinese Foundation for Hepatitis Prevention and Control, and the Qinghai government.  Using the existing provincial China CDC structure, this private-public partnership in Qinghai resulted in a unique two-part school-based immunization program to educate and provide free Hep B vaccination for all children in kindergarten and grade school within the region.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p><p>Between 2006 and 2008, this program demonstrated the feasibility and successful implementation of: \n</p>\n<ol><li>A province-wide catch-up vaccination program that reached 600,000 children in 2,200 schools, and</li>\n<li>A hepatitis B education program incorporated into the school curriculum.</li></ol>\n<p>Impact: The success of this large scale province-wide demonstration program led the Chinese government to announce the adoption of a new policy beginning in 2009 to provide free catch-up hepatitis B vaccination for all children in China under the age of 15 who have not been vaccinated.\n</p>\n<h3><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=7\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Because a high load of HBV in patients is the main cause of hepatitis progression, the ultimate goal in treatment is to eradicate the virus before irreversible liver damage occurs.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>Unfortunately, there are no agents available with high enough <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> and safety to fully eradicate HBV. Neither <a href=\"/wiki/Interferon_alpha\" class=\"mw-redirect\" title=\"Interferon alpha\">interferon alpha</a>, including standard and <a href=\"/wiki/Pegylation\" class=\"mw-redirect\" title=\"Pegylation\">pegylated forms</a>, nor <a href=\"/wiki/Nucleotide_analogues\" class=\"mw-redirect\" title=\"Nucleotide analogues\">nucleotide analogues</a> (including <a href=\"/wiki/Lamivudine\" title=\"Lamivudine\">lamivudine</a>, <a href=\"/wiki/Adefovir_dipivoxil\" class=\"mw-redirect\" title=\"Adefovir dipivoxil\">adefovir dipivoxil</a>, and most recently, <a href=\"/wiki/Entecavir\" title=\"Entecavir\">entecavir</a>) could eradicate HBV <a href=\"/wiki/Covalent\" class=\"mw-redirect\" title=\"Covalent\">covalently</a>-closed-circular <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> in <a href=\"/wiki/Liver\" title=\"Liver\">liver</a> <a href=\"/wiki/Cell_(biology)\" title=\"Cell (biology)\">cells</a>, which is the replication model for HBV recurrence. However, no agents are available to break through the host's immune tolerance to HBV, which is another important reason for persistent infection with HBV,<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> although some patients respond well temporarily to administration of interferon and nucleotide analogues alone or in combination regimens.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> Some <a href=\"/wiki/Traditional_Chinese_herbs\" class=\"mw-redirect\" title=\"Traditional Chinese herbs\">traditional Chinese herbs</a>, such as <a href=\"/wiki/Kushenin\" title=\"Kushenin\">kushenin</a> (<i><a href=\"/wiki/Sophora_flavescens\" title=\"Sophora flavescens\">Sophora flavescens</a></i>) and some complex prescriptions, have some efficacy as <a href=\"/wiki/Antiviral_drug\" title=\"Antiviral drug\">antivirals</a> and in the protection of liver function, although the specific mechanism and components need to be identified. The current treatment in China is the combination of antiviral agents (<a href=\"/wiki/Lamivudine\" title=\"Lamivudine\">lamivudine</a>, <a href=\"/wiki/Adefovir_dipivoxil\" class=\"mw-redirect\" title=\"Adefovir dipivoxil\">adefovir dipivoxil</a>), immune modulators (<a href=\"/wiki/Interferon_alpha\" class=\"mw-redirect\" title=\"Interferon alpha\">interferon alpha</a>, <a href=\"/wiki/Peginterferon_alpha\" class=\"mw-redirect\" title=\"Peginterferon alpha\">peginterferon alpha</a>, <a href=\"/wiki/Thymosin\" title=\"Thymosin\">thymosin</a>), and hepatic protectors (such as <a href=\"/wiki/Glycyrrhizin\" title=\"Glycyrrhizin\">glycyrrhizin</a>, <a href=\"/wiki/Glucuronolactone\" title=\"Glucuronolactone\">glucuronolactone</a>). The Chinese spend around \u019d900 billion (US$110 billion) on these regimens every year.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> Apart from cost, patients and carriers of HBV infection are often confronted with tough conditions and social pressures, although such discrimination is <a href=\"/wiki/Law_of_the_People%27s_Republic_of_China\" title=\"Law of the People&#39;s Republic of China\">illegal</a> in China.\n</p><p>Chinese <a href=\"/wiki/Drug_regulation\" class=\"mw-redirect\" title=\"Drug regulation\">drug regulation</a> authorities have approved Swiss pharmaceutical firm <a href=\"/wiki/Novartis_AG\" class=\"mw-redirect\" title=\"Novartis AG\">Novartis AG</a>'s drug <a href=\"/wiki/Sebivo\" class=\"mw-redirect\" title=\"Sebivo\">Sebivo</a>, a brand name for <a href=\"/wiki/Telbivudine\" title=\"Telbivudine\">telbivudine</a>, as a treatment for chronic <a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">hepatitis B</a> in February 2007. The decision comes shortly after Sebivo was recommended for approval in the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>. The medicine was developed jointly by Novartis and U.S. biotech firm <a href=\"/w/index.php?title=Idenix_Pharmaceuticals&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Idenix Pharmaceuticals (page does not exist)\">Idenix Pharmaceuticals</a> Inc and has been shown in trials to produce significantly greater <a href=\"/w/index.php?title=Viral_suppression&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Viral suppression (page does not exist)\">viral suppression</a> compared to the commonly used treatment <a href=\"/wiki/Lamivudine\" title=\"Lamivudine\">lamivudine</a>. Sebivo won its first major approval in <a href=\"/wiki/Switzerland\" title=\"Switzerland\">Switzerland</a> in September 2006.\n</p>\n<h2><span class=\"mw-headline\" id=\"Governmental_intervention\">Governmental intervention</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=8\" title=\"Edit section: Governmental intervention\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Problems\">Problems</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=9\" title=\"Edit section: Problems\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>There have been relatively few campaigns aimed at ending the practice of reusing needles. For standard preventative practice, a <a href=\"/wiki/Vaccination\" title=\"Vaccination\">vaccination</a> within the first 24 hours after birth is considered the best way to prevent the disease from spreading from mother to child. But it was not until 1992 that China included it as part of a routine <a href=\"/wiki/Immunization\" title=\"Immunization\">immunization</a> program. Even then, the price was relatively high compared with other <a href=\"/wiki/Postnatal\" class=\"mw-redirect\" title=\"Postnatal\">postnatal</a> vaccinations, and families had to pay for it privately. Many have suffered and their families, especially in the poor countryside, decided to go without.\n</p><p>According to China's <a href=\"/wiki/Ministry_of_Health_(China)\" class=\"mw-redirect\" title=\"Ministry of Health (China)\">Ministry of Health</a> website, in 2005 the <a href=\"/wiki/People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"People&#39;s Republic of China\">PRC government</a> belatedly passed a <a href=\"/wiki/Regulation\" title=\"Regulation\">regulation</a> making the vaccination free. The PRC government has set a goal of reducing the overall hepatitis B <a href=\"/wiki/Infection\" title=\"Infection\">infection rate</a> to less than 7% over the next five years, and the rate of infection for children younger than 5 to less than 1%. It has been said by medical observers of prevention programs in the country that the program can be a viable model for other <a href=\"/wiki/Developing_countries\" class=\"mw-redirect\" title=\"Developing countries\">developing countries</a> trying to stop the spread of diseases (including hepatitis B) that can be prevented by vaccines. But a study of some campaigns shows that more than 1 million Chinese babies born each year in the area covered by the government initiated programs are not receiving the vaccination. Officials involved in the hepatitis B vaccination programs say that in many of China's <a href=\"/wiki/Poverty\" title=\"Poverty\">poverty</a>-stricken rural areas, children are delivered at home in remote mountain villages or <a href=\"/wiki/Nomadic\" class=\"mw-redirect\" title=\"Nomadic\">nomadic</a> herders' tents, far from <a href=\"/wiki/Hospitals\" class=\"mw-redirect\" title=\"Hospitals\">hospitals</a> and access to medical information. The <a href=\"/wiki/Chinese_Center_for_Disease_Control_and_Prevention\" title=\"Chinese Center for Disease Control and Prevention\">Chinese Center for Disease Control and Prevention</a> (<a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20070614161359/http://www.chinacdc.net.cn/\">China CDC</a>) have conducted research that supports the evidence that \"there was and is still a huge bottleneck to ensure the delivery of the timely birth <a href=\"/wiki/Effective_dose_(pharmacology)\" title=\"Effective dose (pharmacology)\">dosage</a> to home births\".\n</p><p>Another problem is the growing size of China's <a href=\"/wiki/Migrant_labor\" class=\"mw-redirect\" title=\"Migrant labor\">migrant labor</a> force or \"floating population.\" <a href=\"/wiki/Farmers\" class=\"mw-redirect\" title=\"Farmers\">Farmers</a> or <a href=\"/wiki/Peasants\" class=\"mw-redirect\" title=\"Peasants\">peasants</a> who become urban laborers move frequently around the country and often do not seek medical attention. The immunization rate among them remains low, said China CDC. One major problem facing Chinese people infected with hepatitis B is that illegal blood testing is required by most employers in China. Anyone that tests positive for hepatitis B is either denied employment or fired. Laws do exist to protect the privacy of employees and job seekers but they are not enforced.\n</p>\n<h3><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=10\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Hepatitis B and its related disorders are important <a href=\"/wiki/Public_health\" title=\"Public health\">public health</a> issues in China, which not only presents challenges for doctors and scientists but also increases the burden for the government. Last year, the <a href=\"/wiki/Government_of_the_People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"Government of the People&#39;s Republic of China\">Chinese Government</a> funded research with around <a href=\"/wiki/%C6%9D\" title=\"\u019d\">\u019d</a>3 billion (<a href=\"/wiki/US$\" class=\"mw-redirect\" title=\"US$\">US$</a>390 million), mainly against hepatitis B and related diseases over the next decade.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>Research will include: large <a href=\"/wiki/Retrospective_cohort_study\" title=\"Retrospective cohort study\">retrospective</a> and <a href=\"/wiki/Prospective_cohort_study\" title=\"Prospective cohort study\">prospective</a> studies of the population vaccinated against hepatitis B and the incidence of HCC; <a href=\"/wiki/Genetic_variation\" title=\"Genetic variation\">genetic variation</a> in HBV and its subtypes, and mutations in HBV DNA in the response to interferon and nucleotide analogues; host-gene variation and the therapeutic response, including single-nuclear <a href=\"/wiki/Polymorphism_(biology)\" title=\"Polymorphism (biology)\">polymorphisms</a> and gene copy-number variations; <a href=\"/wiki/Virus#Genetic_mutation\" title=\"Virus\">virus mutation</a> and the mechanism of the <a href=\"/wiki/Immune_response\" title=\"Immune response\">immune response</a> in <a href=\"/wiki/Fulminant\" title=\"Fulminant\">fulminant</a> liver failure, and the immunological factors which cause liver injury and the markers which predict reduction in liver function; assessment and prediction of <a href=\"/wiki/Liver_fibrosis\" class=\"mw-redirect\" title=\"Liver fibrosis\">liver fibrosis</a> by non-invasive biomarkers, and interference with fibrosis from small chemical compounds or <a href=\"/wiki/Traditional_Chinese_medicines\" class=\"mw-redirect\" title=\"Traditional Chinese medicines\">traditional Chinese medicines</a>; prediction of the development, <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>, and <a href=\"/wiki/Prognosis\" title=\"Prognosis\">prognosis</a> of HCC by molecular typing; and the identification of important signal transduction pathways in HCC and the development of new small chemical compounds to target HCC.\n</p>\n<h3><span class=\"mw-headline\" id=\"Progress\">Progress</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=11\" title=\"Edit section: Progress\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>To measure the results, the <a href=\"/wiki/Government_of_the_People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"Government of the People&#39;s Republic of China\">Government</a> also set goals that corresponded to these research projects. The goals include: completion of the <a href=\"/w/index.php?title=Immunoprophylaxis&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Immunoprophylaxis (page does not exist)\">immunoprophylaxis</a> strategy, such as <a href=\"/wiki/HBV_vaccine\" class=\"mw-redirect\" title=\"HBV vaccine\">HBV vaccine</a>, to decrease the incidence of HCC by more than 10%; identification of molecular <a href=\"/wiki/Biomarkers\" class=\"mw-redirect\" title=\"Biomarkers\">biomarkers</a>, and the creation of molecular-typing <a href=\"/w/index.php?title=Diagnostic_kit&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Diagnostic kit (page does not exist)\">diagnostic kits</a> for the prediction of the therapeutic response; the development of regimens to treat HBV; the identification of biomarkers to predict the aggressiveness of severe hepatitis B and the development of a kit for early diagnosis of <a href=\"/wiki/Liver_cirrhosis\" class=\"mw-redirect\" title=\"Liver cirrhosis\">liver cirrhosis</a>; the identification of markers (biological and <a href=\"/wiki/Genomic\" class=\"mw-redirect\" title=\"Genomic\">genomic</a>, and small molecules) for early diagnosis and to predict <a href=\"/wiki/Relapse\" title=\"Relapse\">recurrence</a> and <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>, and the development of new drugs for HCC, to increase the rate of early diagnosis by more than 20% and 5-year survival by more than 5%. The fight against HBV and its related disorders is now thought of as a long-term one by the health authorities.\n</p>\n<h2><span class=\"mw-headline\" id=\"Social_impact\">Social impact</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=12\" title=\"Edit section: Social impact\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Discrimination\">Discrimination</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=13\" title=\"Edit section: Discrimination\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">Hepatitis B</a> sufferers in China frequently face <a href=\"/wiki/Discrimination\" title=\"Discrimination\">discrimination</a> in all aspects of life and work. For example, many Chinese <a href=\"/wiki/Employers\" class=\"mw-redirect\" title=\"Employers\">employers</a> and <a href=\"/wiki/Universities\" class=\"mw-redirect\" title=\"Universities\">universities</a> refuse to accept anyone who tests positive. Some <a href=\"/wiki/Kindergartens\" class=\"mw-redirect\" title=\"Kindergartens\">kindergartens</a> refuse admission to children who are <a href=\"/wiki/Asymptomatic_carrier\" title=\"Asymptomatic carrier\">carriers</a> of the virus. The hepatitis problem is a reflection of the vast developmental gap between China's <a href=\"/wiki/Rural\" class=\"mw-redirect\" title=\"Rural\">rural</a> and <a href=\"/wiki/Urban_area\" title=\"Urban area\">urban</a> areas. The largest problem facing Chinese people infected with HBV is that illegal blood testing is required by most employers in China.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> According to a report by <a href=\"/wiki/PBS\" title=\"PBS\">PBS</a>, faking blood tests by hiring uninfected individuals to take them has become widespread.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> Following an incident involving a Hepatitis B carrier's killing of an employer and other calls against discriminatory employment practices, China's ministries of health and personnel announced that Hepatitis B carriers must not be discriminated against when seeking employment and education.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> While the laws exist to protect the privacy of employees and job seekers, many believe that they are not enforced.\n</p>\n<h3><span id=\".22In_the_Hepatitis_B_Camp.22\"></span><span class=\"mw-headline\" id=\"&quot;In_the_Hepatitis_B_Camp&quot;\">\"In the Hepatitis B Camp\"</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=14\" title=\"Edit section: &quot;In the Hepatitis B Camp&quot;\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>\"In the Hepatitis B Camp\" is a popular website for hepatitis B carriers' <a href=\"/wiki/Human_rights_in_China\" title=\"Human rights in China\">human rights in China</a>. Its online forum is the world's biggest such forum with over 300,000 members. The website was first shut down by the Chinese government in November 2007. Lu Jun, the head of the rights group, managed to reopen the website by moving it to an overseas server, but the authorities in May 2008 began blocking access to the website within China, only 10 days after government officials participated in an event for <a href=\"/wiki/World_Hepatitis_Day\" title=\"World Hepatitis Day\">World Hepatitis Day</a> at the <a href=\"/wiki/Great_Wall_of_China\" title=\"Great Wall of China\">Great Wall of China</a>. An official had told the head of the rights group, Lu Jun, at the time that the closure was due to the Beijing Olympic Games.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=15\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Jade_Ribbon_Campaign\" title=\"Jade Ribbon Campaign\">Jade Ribbon Campaign</a></li>\n<li><a href=\"/wiki/HIV/AIDS_in_the_People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"HIV/AIDS in the People&#39;s Republic of China\">HIV/AIDS in the People's Republic of China</a></li>\n<li><a href=\"/wiki/Hepatitis\" title=\"Hepatitis\">Hepatitis</a></li>\n<li><a href=\"/wiki/Public_health_in_the_People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"Public health in the People&#39;s Republic of China\">Public health in the People's Republic of China</a></li>\n<li><a href=\"/wiki/Tuberculosis_in_China\" title=\"Tuberculosis in China\">Tuberculosis in China</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=16\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20091203232419/http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html\">\"Hepatitis B Surveillance and control\"</a>. World Health Organization. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html\">the original</a> on 2009-12-03<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-10-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Hepatitis+B+Surveillance+and+control&amp;rft.pub=World+Health+Organization&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fcsr%2Fdisease%2Fhepatitis%2Fwhocdscsrlyo20022%2Fen%2Findex4.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15602165-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15602165_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15602165_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV (2004). \"Global epidemiology of hepatitis B virus\". <i>J. Clin. Gastroenterol</i>. <b>38</b> (10 Suppl 3): S158\u201368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00004836-200411003-00008\">10.1097/00004836-200411003-00008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15602165\">15602165</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Gastroenterol.&amp;rft.atitle=Global+epidemiology+of+hepatitis+B+virus&amp;rft.volume=38&amp;rft.issue=10+Suppl+3&amp;rft.pages=S158-68&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1097%2F00004836-200411003-00008&amp;rft_id=info%3Apmid%2F15602165&amp;rft.aulast=Custer&amp;rft.aufirst=B&amp;rft.au=Sullivan%2C+SD&amp;rft.au=Hazlet%2C+TK&amp;rft.au=Iloeje%2C+U&amp;rft.au=Veenstra%2C+DL&amp;rft.au=Kowdley%2C+KV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liu, J.; Fan, D. (2007). \"Hepatitis B in China\". <i>The Lancet</i>. <b>369</b> (9573): 1582\u20131583. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2807%2960723-5\">10.1016/S0140-6736(07)60723-5</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Hepatitis+B+in+China&amp;rft.volume=369&amp;rft.issue=9573&amp;rft.pages=1582-1583&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2960723-5&amp;rft.aulast=Liu&amp;rft.aufirst=J.&amp;rft.au=Fan%2C+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16471211-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16471211_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Liang, X. F.; Chen, Y. S.; Wang, X. J.; He, X.; Chen, L. J.; Wang, J.; Lin, C. Y.; Bai, H. Q.; Yan, J.; Cui, G.; Yu, J. J. (2005). \"A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old\". <i>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</i>. <b>26</b> (9): 655\u2013658. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16471211\">16471211</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Zhonghua+liu+xing+bing+xue+za+zhi+%3D+Zhonghua+liuxingbingxue+zazhi&amp;rft.atitle=A+study+on+the+sero-epidemiology+of+hepatitis+B+in+Chinese+population+aged+over+3-years+old&amp;rft.volume=26&amp;rft.issue=9&amp;rft.pages=655-658&amp;rft.date=2005&amp;rft_id=info%3Apmid%2F16471211&amp;rft.aulast=Liang&amp;rft.aufirst=X.+F.&amp;rft.au=Chen%2C+Y.+S.&amp;rft.au=Wang%2C+X.+J.&amp;rft.au=He%2C+X.&amp;rft.au=Chen%2C+L.+J.&amp;rft.au=Wang%2C+J.&amp;rft.au=Lin%2C+C.+Y.&amp;rft.au=Bai%2C+H.+Q.&amp;rft.au=Yan%2C+J.&amp;rft.au=Cui%2C+G.&amp;rft.au=Yu%2C+J.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sun, Z.; Ming, L.; Zhu, X.; Lu, J. (2002). \"Prevention and control of hepatitis B in China\". <i>Journal of Medical Virology</i>. <b>67</b> (3): 447\u2013450. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jmv.10094\">10.1002/jmv.10094</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12116043\">12116043</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medical+Virology&amp;rft.atitle=Prevention+and+control+of+hepatitis+B+in+China&amp;rft.volume=67&amp;rft.issue=3&amp;rft.pages=447-450&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1002%2Fjmv.10094&amp;rft_id=info%3Apmid%2F12116043&amp;rft.aulast=Sun&amp;rft.aufirst=Z.&amp;rft.au=Ming%2C+L.&amp;rft.au=Zhu%2C+X.&amp;rft.au=Lu%2C+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">CW, Si. \"Current status and problem of chronic hepatitis B\". <i>Clin Med J</i> (in Chinese) (4): 1\u20132.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Med+J&amp;rft.atitle=Current+status+and+problem+of+chronic+hepatitis+B&amp;rft.issue=4&amp;rft.pages=1-2&amp;rft.aulast=CW&amp;rft.aufirst=Si&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jia; Zhuang, H. (2004). \"The overview of the seminar on chronic hepatitis B\". <i>Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology</i>. <b>12</b> (11): 698\u2013699. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15623388\">15623388</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Zhonghua+gan+zang+bing+za+zhi+%3D+Zhonghua+ganzangbing+zazhi+%3D+Chinese+journal+of+hepatology&amp;rft.atitle=The+overview+of+the+seminar+on+chronic+hepatitis+B&amp;rft.volume=12&amp;rft.issue=11&amp;rft.pages=698-699&amp;rft.date=2004&amp;rft_id=info%3Apmid%2F15623388&amp;rft.au=Jia&amp;rft.au=Zhuang%2C+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wang, XJ; Zhang, RZ; Hu, YS; Liang, XF (2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jbjc.org/EN/abstract/abstract4350.shtml#\">\"Analysis on epidemic status of viral hepatitis in China\"</a>. <i>Disease Surveillance</i> (in Chinese) (19): 290\u2013293. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3784/j.issn.1003-9961.2004.8.290\">10.3784/j.issn.1003-9961.2004.8.290</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1003-9961\">1003-9961</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Surveillance&amp;rft.atitle=Analysis+on+epidemic+status+of+viral+hepatitis+in+China&amp;rft.issue=19&amp;rft.pages=290-293&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.3784%2Fj.issn.1003-9961.2004.8.290&amp;rft.issn=1003-9961&amp;rft.aulast=Wang&amp;rft.aufirst=XJ&amp;rft.au=Zhang%2C+RZ&amp;rft.au=Hu%2C+YS&amp;rft.au=Liang%2C+XF&amp;rft_id=http%3A%2F%2Fwww.jbjc.org%2FEN%2Fabstract%2Fabstract4350.shtml%23&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cui, FQ; Wang, XJ; Laing, XF (Nov 2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGJM200603020.htm\">\"Epidemiological Analysis on Reported Hepatitis B Under 15 Years in China\"</a>. <i>China's immunization</i> (in Chinese). <b>12</b> (3). <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1006-916X\">1006-916X</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=China%27s+immunization&amp;rft.atitle=Epidemiological+Analysis+on+Reported+Hepatitis+B+Under+15+Years+in+China&amp;rft.volume=12&amp;rft.issue=3&amp;rft.date=2006-11&amp;rft.issn=1006-916X&amp;rft.aulast=Cui&amp;rft.aufirst=FQ&amp;rft.au=Wang%2C+XJ&amp;rft.au=Laing%2C+XF&amp;rft_id=http%3A%2F%2Fen.cnki.com.cn%2FArticle_en%2FCJFDTOTAL-ZGJM200603020.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chen Jonathan J (2012-06-01). <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.1007/s00038-011-0289-x\">\"A model program for hepatitis B vaccination and education of schoolchildren in rural China\"</a>. <i>International Journal of Public Health</i>. Stanford School of Medicine. <b>57</b> (3): 581\u2013588. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00038-011-0289-x\">10.1007/s00038-011-0289-x</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-06-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Public+Health&amp;rft.atitle=A+model+program+for+hepatitis+B+vaccination+and+education+of+schoolchildren+in+rural+China&amp;rft.volume=57&amp;rft.issue=3&amp;rft.pages=581-588&amp;rft.date=2012-06-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs00038-011-0289-x&amp;rft.au=Chen+Jonathan+J&amp;rft_id=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00038-011-0289-x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://sm.stanford.edu/archive/stanmed/2008spring/safety_shot.html\">\"Safety Shot: Three Young Americans stop at nothing to halt one of Asia's Biggest Killers\"</a>. Stanford School of Medicine. 2008-04-01<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-03-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Safety+Shot%3A+Three+Young+Americans+stop+at+nothing+to+halt+one+of+Asia%27s+Biggest+Killers&amp;rft.pub=Stanford+School+of+Medicine&amp;rft.date=2008-04-01&amp;rft_id=http%3A%2F%2Fsm.stanford.edu%2Farchive%2Fstanmed%2F2008spring%2Fsafety_shot.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sung, J. J.; Wong, M. L.; Bowden, S.; Liew, C. T.; Hui, A. Y.; Wong, V. W.; Leung, N. W.; Locarnini, S.; Chan, H. L. (2005). \"Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy\". <i>Gastroenterology</i>. <b>128</b> (7): 1890\u20131897. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.gastro.2005.03.009\">10.1053/j.gastro.2005.03.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15940624\">15940624</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=Intrahepatic+hepatitis+B+virus+covalently+closed+circular+DNA+can+be+a+predictor+of+sustained+response+to+therapy&amp;rft.volume=128&amp;rft.issue=7&amp;rft.pages=1890-1897&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2005.03.009&amp;rft_id=info%3Apmid%2F15940624&amp;rft.aulast=Sung&amp;rft.aufirst=J.+J.&amp;rft.au=Wong%2C+M.+L.&amp;rft.au=Bowden%2C+S.&amp;rft.au=Liew%2C+C.+T.&amp;rft.au=Hui%2C+A.+Y.&amp;rft.au=Wong%2C+V.+W.&amp;rft.au=Leung%2C+N.+W.&amp;rft.au=Locarnini%2C+S.&amp;rft.au=Chan%2C+H.+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lok, A. S. -F. (2005). \"The Maze of Treatments for Hepatitis B\". <i>New England Journal of Medicine</i>. <b>352</b> (26): 2743\u20132746. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMe058119\">10.1056/NEJMe058119</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15987924\">15987924</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=The+Maze+of+Treatments+for+Hepatitis+B&amp;rft.volume=352&amp;rft.issue=26&amp;rft.pages=2743-2746&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMe058119&amp;rft_id=info%3Apmid%2F15987924&amp;rft.aulast=Lok&amp;rft.aufirst=A.+S.+-F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Janssen, H.; Van Zonneveld, M.; Senturk, H.; Zeuzem, S.; Akarca, U.; Cakaloglu, Y.; Simon, C.; So, T.; Gerken, G.; De Man, R. A.; Niesters, H. G.; Zondervan, P.; Hansen, B.; Schalm, S. W. (2005). \"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial\". <i>The Lancet</i>. <b>365</b> (9454): 123\u2013129. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2805%2917701-0\">10.1016/S0140-6736(05)17701-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15639293\">15639293</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Pegylated+interferon+alfa-2b+alone+or+in+combination+with+lamivudine+for+HBeAg-positive+chronic+hepatitis+B%3A+a+randomised+trial&amp;rft.volume=365&amp;rft.issue=9454&amp;rft.pages=123-129&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2805%2917701-0&amp;rft_id=info%3Apmid%2F15639293&amp;rft.aulast=Janssen&amp;rft.aufirst=H.&amp;rft.au=Van+Zonneveld%2C+M.&amp;rft.au=Senturk%2C+H.&amp;rft.au=Zeuzem%2C+S.&amp;rft.au=Akarca%2C+U.&amp;rft.au=Cakaloglu%2C+Y.&amp;rft.au=Simon%2C+C.&amp;rft.au=So%2C+T.&amp;rft.au=Gerken%2C+G.&amp;rft.au=De+Man%2C+R.+A.&amp;rft.au=Niesters%2C+H.+G.&amp;rft.au=Zondervan%2C+P.&amp;rft.au=Hansen%2C+B.&amp;rft.au=Schalm%2C+S.+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhuang, H (2005). \"The challenge of hepatitis B infection in China\". <i>Chin J Infect Dis</i> (in Chinese) (23): 2\u20136.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chin+J+Infect+Dis&amp;rft.atitle=The+challenge+of+hepatitis+B+infection+in+China&amp;rft.issue=23&amp;rft.pages=2-6&amp;rft.date=2005&amp;rft.aulast=Zhuang&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.most.gov.cn/\">\"The People's Republic of China Ministry of Science and Technology\"</a> (in Chinese). Beijing, China: Chinese government<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-10-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+People%27s+Republic+of+China+Ministry+of+Science+and+Technology&amp;rft.place=Beijing%2C+China&amp;rft.pub=Chinese+government&amp;rft_id=http%3A%2F%2Fwww.most.gov.cn%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100110134946/http://www.nsfc.gov.cn/nsfc2009/index.htm\">\"National Natural Science Foundation of China\"</a>. Chinese government. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nsfc.gov.cn/nsfc2009/index.htm\">the original</a> on 2010-01-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-10-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=National+Natural+Science+Foundation+of+China&amp;rft.pub=Chinese+government&amp;rft_id=http%3A%2F%2Fwww.nsfc.gov.cn%2Fnsfc2009%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chinadaily.com.cn/english/doc/2005-01/21/content_411013.htm\">\"Hep B carriers allowed to join public service\"</a>. <i>China Daily</i>. 21 May 2005<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=China+Daily&amp;rft.atitle=Hep+B+carriers+allowed+to+join+public+service&amp;rft.date=2005-05-21&amp;rft_id=http%3A%2F%2Fwww.chinadaily.com.cn%2Fenglish%2Fdoc%2F2005-01%2F21%2Fcontent_411013.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><i><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pbs.org/newshour/updates/asia/july-dec11/china_10-06.html\">Faking Blood Tests to Avoid Discrimination in China</a></i>.  newshours.pbs.org. Accessed 2011-10-06.</span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Liu Anqi (30 December 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://english.cctv.com/program/chinatoday/20091230/101108.shtml\">\"Health Ministry to cancel Hepatitis B tests for employment &amp; school enrollment\"</a>. <i>CCTV.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2 June</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CCTV.com&amp;rft.atitle=Health+Ministry+to+cancel+Hepatitis+B+tests+for+employment+%26+school+enrollment&amp;rft.date=2009-12-30&amp;rft.au=Liu+Anqi&amp;rft_id=http%3A%2F%2Fenglish.cctv.com%2Fprogram%2Fchinatoday%2F20091230%2F101108.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Kwong, Robin (2008-06-25). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ft.com/cms/s/0/ca0e927c-4201-11dd-a5e8-0000779fd2ac.html\">\"Group warns China on website shutdown\"</a>. Hong Kong: Financial Times<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-10-23</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Group+warns+China+on+website+shutdown&amp;rft.place=Hong+Kong&amp;rft.pub=Financial+Times&amp;rft.date=2008-06-25&amp;rft.aulast=Kwong&amp;rft.aufirst=Robin&amp;rft_id=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fca0e927c-4201-11dd-a5e8-0000779fd2ac.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatitis+B+in+China\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Hepatitis_B_in_China&amp;action=edit&amp;section=17\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/countries/chn/en/\"><b>WHO</b>: China</a>\u2014World Health Organization Country Profile</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.wpro.who.int/china\"><b>WHO</b>: China Office</a>\u2014World Health Organization China Office</li>\n<li><span class=\"languageicon\">(in Chinese)</span> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hbvhbv.com/\">\u4e59\u809d\u00b7\u8bba\u575b\u00b7\u4e59\u809d\u75c5\u6bd2\u643a\u5e26\u8005\u7684\u7f51\u4e0a\u5bb6\u56ed-\u809d\u80c6\u76f8\u7167</a>\u2014\"In the Hepatitis Camp\"</li>\n<li><span class=\"languageicon\">(in English)</span> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hbvhbv.com/english/\">Hepatitis B Carriers BBS</a>\u2014\"In the Hepatitis Camp\"</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Health_in_China\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Health_in_China\" title=\"Template:Health in China\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Health_in_China\" title=\"Template talk:Health in China\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Health_in_China&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Health_in_China\" style=\"font-size:114%;margin:0 4em\">Health in China</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Health_care\" title=\"Health care\">Healthcare</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Health_in_China\" title=\"Health in China\">Health</a></li>\n<li><a href=\"/wiki/Disease_surveillance_in_China\" title=\"Disease surveillance in China\">Disease surveillance</a></li>\n<li><a href=\"/wiki/Healthcare_reform_in_China\" title=\"Healthcare reform in China\">Healthcare system reform</a></li>\n<li><a href=\"/wiki/Women%27s_health_in_China\" title=\"Women&#39;s health in China\">Women's health</a></li>\n<li><a href=\"/wiki/Health_informatics_in_China\" title=\"Health informatics in China\">Health informatics</a></li>\n<li><a href=\"/wiki/Smoking_in_China\" title=\"Smoking in China\">Tobacco Control Association</a></li>\n<li><a href=\"/wiki/Barefoot_doctor\" title=\"Barefoot doctor\">Barefoot doctor</a></li>\n<li><a href=\"/wiki/Patriotic_Health_Campaign\" title=\"Patriotic Health Campaign\">Patriotic Health Campaign</a></li>\n<li><a href=\"/wiki/China_Welfare_Institute\" title=\"China Welfare Institute\">China Welfare Institute</a></li>\n<li><a href=\"/wiki/Hospitals_in_China\" class=\"mw-redirect\" title=\"Hospitals in China\">Hospitals in China</a></li>\n<li><a href=\"/wiki/Category:Medical_schools_in_China\" title=\"Category:Medical schools in China\">Medical schools</a></li>\n<li><a href=\"/wiki/Organ_transplantation_in_China\" title=\"Organ transplantation in China\">Organ transplantation</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Medicine\" title=\"Medicine\">Medicine</a> <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">and pharmaceutical</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Medicine_in_China\" title=\"Medicine in China\">Medicine</a></li>\n<li><a href=\"/wiki/Traditional_Chinese_medicine\" title=\"Traditional Chinese medicine\">Traditional Chinese medicine</a></li>\n<li><a href=\"/wiki/Pharmacy_in_China\" title=\"Pharmacy in China\">Pharmacy</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_China\" title=\"Pharmaceutical industry in China\">Pharmaceutical industry</a></li>\n<li><a href=\"/wiki/Biotechnology_industry_in_China\" title=\"Biotechnology industry in China\">Biotechnology</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Diseases\" class=\"mw-redirect\" title=\"Diseases\">Diseases</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Avian_influenza\" title=\"Avian influenza\">Avian influenza</a></li>\n<li><a href=\"/wiki/Porcine_Reproductive_and_Respiratory_Syndrome_Virus\" class=\"mw-redirect\" title=\"Porcine Reproductive and Respiratory Syndrome Virus\">Blue-ear disease</a></li>\n<li><a href=\"/wiki/Cardiovascular_disease_in_China\" title=\"Cardiovascular disease in China\">Cardiovascular disease</a></li>\n<li><a href=\"/wiki/Chronic_diseases_in_China\" class=\"mw-redirect\" title=\"Chronic diseases in China\">Chronic diseases</a></li>\n<li><a href=\"/wiki/Enterovirus\" title=\"Enterovirus\">Enterovirus 71 (EV71)</a></li>\n<li><a href=\"/wiki/Fujian_flu\" title=\"Fujian flu\">Fujian flu</a></li>\n<li><a class=\"mw-selflink selflink\">Hepatitis B</a></li>\n<li><a href=\"/wiki/HIV/AIDS_in_China\" title=\"HIV/AIDS in China\">HIV/AIDS</a></li>\n<li><a href=\"/wiki/Iodine_deficiency_in_China\" title=\"Iodine deficiency in China\">Iodine deficiency</a></li>\n<li><a href=\"/wiki/2009_Chinese_lead_poisoning_scandal\" title=\"2009 Chinese lead poisoning scandal\">lead poisoning scandal</a></li>\n<li><a href=\"/wiki/Leprosy_in_China\" title=\"Leprosy in China\">Leprosy</a></li>\n<li><a href=\"/wiki/Mental_health_in_China\" title=\"Mental health in China\">Mental health</a></li>\n<li><a href=\"/wiki/Obesity_in_China\" title=\"Obesity in China\">Obesity</a></li>\n<li><a href=\"/wiki/Pneumonic_plague#China\" title=\"Pneumonic plague\">Pneumonic plague</a></li>\n<li><a href=\"/wiki/Severe_acute_respiratory_syndrome\" title=\"Severe acute respiratory syndrome\">SARS</a> (<a href=\"/wiki/Progress_of_the_SARS_outbreak\" class=\"mw-redirect\" title=\"Progress of the SARS outbreak\">outbreak progress</a>)</li>\n<li><a href=\"/wiki/Stroke_in_China\" title=\"Stroke in China\">Stroke</a></li>\n<li><a href=\"/wiki/2009_flu_pandemic_in_Asia#China_.28People.27s_Republic_of_China.29\" title=\"2009 flu pandemic in Asia\">Swine influenza outbreak</a></li>\n<li><a href=\"/wiki/Tuberculosis_in_China\" title=\"Tuberculosis in China\">Tuberculosis</a></li>\n<li><a href=\"/wiki/Category:Disease-related_deaths_in_China\" title=\"Category:Disease-related deaths in China\">Disease-related deaths</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ministry_(government_department)\" title=\"Ministry (government department)\">Government</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/w/index.php?title=National_Health_Commission&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"National Health Commission (page does not exist)\">National Health Commission</a></li>\n<li><a href=\"/wiki/Chinese_Center_for_Disease_Control_and_Prevention\" title=\"Chinese Center for Disease Control and Prevention\">Chinese Center for Disease Control and Prevention</a></li>\n<li><a href=\"/w/index.php?title=China_Drug_Administration&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"China Drug Administration (page does not exist)\">China Drug Administration</a></li>\n<li><a href=\"/wiki/State_Administration_of_Traditional_Chinese_Medicine\" title=\"State Administration of Traditional Chinese Medicine\">State Administration of Traditional Chinese Medicine</a></li>\n<li><a href=\"/wiki/Department_of_Health_(Hong_Kong)\" title=\"Department of Health (Hong Kong)\"><i>Hong Kong Department of Health</i></a> *</li>\n<li><a href=\"/wiki/Secretariat_for_Social_Affairs_and_Culture_(Macau)\" title=\"Secretariat for Social Affairs and Culture (Macau)\"><i>Macau Secretariat for Social Affairs and Culture</i></a> *</li>\n<li><a href=\"/wiki/General_Administration_of_Customs\" title=\"General Administration of Customs\">General Administration of Customs</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other related issues</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Demographics_of_China\" title=\"Demographics of China\">Demographics</a></li>\n<li><a href=\"/wiki/China_dust_storms\" class=\"mw-redirect\" title=\"China dust storms\">Dust storms</a></li>\n<li><a href=\"/wiki/Environment_of_China\" title=\"Environment of China\">Environment</a></li>\n<li><a href=\"/wiki/Food_safety_in_China\" title=\"Food safety in China\">Food safety</a></li>\n<li><a href=\"/wiki/Illegal_drug_trade_in_China\" title=\"Illegal drug trade in China\">Illegal drug trade</a></li>\n<li><a href=\"/wiki/Pollution_in_China\" title=\"Pollution in China\">Pollution</a></li>\n<li><a href=\"/wiki/Poverty_in_China\" title=\"Poverty in China\">Poverty</a></li>\n<li><a href=\"/wiki/Prostitution_in_China\" title=\"Prostitution in China\">Prostitution</a></li>\n<li><a href=\"/wiki/Smoking_in_China\" title=\"Smoking in China\">Smoking</a></li>\n<li><a href=\"/wiki/Vegetarianism_in_China\" class=\"mw-redirect\" title=\"Vegetarianism in China\">Vegetarianism</a></li>\n<li><a href=\"/wiki/Violence_against_doctors_in_China\" title=\"Violence against doctors in China\">Violence against doctors in China</a>\n<ul><li><a href=\"/wiki/Yi_Nao\" class=\"mw-redirect\" title=\"Yi Nao\">Yi Nao</a></li></ul></li>\n<li><a href=\"/wiki/Water_supply_and_sanitation_in_China\" title=\"Water supply and sanitation in China\">Water supply and sanitation</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Studies</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/China-Cornell-Oxford_Project\" class=\"mw-redirect\" title=\"China-Cornell-Oxford Project\">China-Cornell-Oxford Project</a> <i>(<a href=\"/wiki/The_China_Study\" title=\"The China Study\">The China Study</a>)</i></li>\n<li><a href=\"/wiki/China_Health_and_Nutrition_Survey\" title=\"China Health and Nutrition Survey\">China Health and Nutrition Survey</a></li>\n<li><a href=\"/wiki/China_Family_Panel_Studies\" title=\"China Family Panel Studies\">China Family Panel Studies</a></li>\n<li><a href=\"/wiki/China_Health_and_Retirement_Longitudinal_Study\" title=\"China Health and Retirement Longitudinal Study\">China Health and Retirement Longitudinal Study</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>&#160;* Of special administrative regions</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2198\nCached time: 20180913112302\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.284 seconds\nReal time usage: 0.335 seconds\nPreprocessor visited node count: 1336/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 57685/2097152 bytes\nTemplate argument size: 138/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 3/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 24977/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.137/10.000 seconds\nLua memory usage: 3.81 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  252.968      1 -total\n 66.59%  168.442      1 Template:Reflist\n 31.16%   78.833     13 Template:Cite_journal\n 18.04%   45.633      5 Template:Cite_web\n 16.84%   42.591      1 Template:Refimprove\n 10.49%   26.534      1 Template:Ambox\n  5.63%   14.246      1 Template:Health_in_the_People's_Republic_of_China\n  4.48%   11.345      2 Template:Link_language\n  4.41%   11.153      2 Template:Cite_news\n  4.17%   10.544      1 Template:Cn_icon\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:6127515-0!canonical and timestamp 20180913112302 and revision id 846584823\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%83%D8%A8%D8%AF_%D9%81%D9%8A_%D8%A7%D9%84%D8%B5%D9%8A%D9%86","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0643\u0628\u062f \u0641\u064a \u0627\u0644\u0635\u064a\u0646"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/H%C3%A9patite_B_en_Chine","langname":"French","autonym":"fran\u00e7ais","*":"H\u00e9patite B en Chine"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E4%B9%99%E8%82%9D%E6%AD%A7%E8%A7%86","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u4e59\u809d\u6b67\u89c6"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_Chinese-language_sources_(zh)"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_January_2009"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","hidden":"","*":"Articles_with_Chinese-language_external_links"},{"sortkey":"","*":"Health_in_China"},{"sortkey":"","*":"Hepatitis_B"}],"links":[{"ns":14,"exists":"","*":"Category:Articles needing additional references from January 2009"},{"ns":14,"exists":"","*":"Category:Disease-related deaths in China"},{"ns":14,"exists":"","*":"Category:Medical schools in China"},{"ns":10,"exists":"","*":"Template:ISO 639 name zh"},{"ns":10,"exists":"","*":"Template:ISO 639 name en"},{"ns":10,"exists":"","*":"Template:Health in China"},{"ns":0,"exists":"","*":"2009 Chinese lead poisoning scandal"},{"ns":0,"exists":"","*":"2009 flu pandemic in Asia"},{"ns":0,"exists":"","*":"AIDS"},{"ns":0,"exists":"","*":"Adefovir dipivoxil"},{"ns":0,"exists":"","*":"Antiviral drug"},{"ns":0,"exists":"","*":"Asymptomatic carrier"},{"ns":0,"exists":"","*":"Avian influenza"},{"ns":0,"exists":"","*":"Barefoot doctor"},{"ns":0,"exists":"","*":"Biomarkers"},{"ns":0,"exists":"","*":"Biotechnology industry in China"},{"ns":0,"exists":"","*":"Cardiovascular disease in China"},{"ns":0,"exists":"","*":"Cell (biology)"},{"ns":0,"exists":"","*":"China"},{"ns":0,"exists":"","*":"China-Cornell-Oxford Project"},{"ns":0,"exists":"","*":"China Family Panel Studies"},{"ns":0,"exists":"","*":"China Health and Nutrition Survey"},{"ns":0,"exists":"","*":"China Health and Retirement Longitudinal Study"},{"ns":0,"exists":"","*":"China Welfare Institute"},{"ns":0,"exists":"","*":"China dust storms"},{"ns":0,"exists":"","*":"Chinese Center for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Chronic diseases in China"},{"ns":0,"exists":"","*":"Cirrhosis"},{"ns":0,"exists":"","*":"Covalent"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"Demographics of China"},{"ns":0,"exists":"","*":"Department of Health (Hong Kong)"},{"ns":0,"exists":"","*":"Developing countries"},{"ns":0,"exists":"","*":"Developing nations"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Discrimination"},{"ns":0,"exists":"","*":"Disease surveillance in China"},{"ns":0,"exists":"","*":"Diseases"},{"ns":0,"exists":"","*":"Drug regulation"},{"ns":0,"exists":"","*":"Effective dose (pharmacology)"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Employers"},{"ns":0,"exists":"","*":"Endemic (epidemiology)"},{"ns":0,"exists":"","*":"Entecavir"},{"ns":0,"exists":"","*":"Enterovirus"},{"ns":0,"exists":"","*":"Environment of China"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Farmers"},{"ns":0,"exists":"","*":"Food safety in China"},{"ns":0,"exists":"","*":"Fujian flu"},{"ns":0,"exists":"","*":"Fulminant"},{"ns":0,"exists":"","*":"GAVI Alliance"},{"ns":0,"exists":"","*":"Gao Qiang"},{"ns":0,"exists":"","*":"General Administration of Customs"},{"ns":0,"exists":"","*":"Genetic variation"},{"ns":0,"exists":"","*":"Genomic"},{"ns":0,"exists":"","*":"Global Alliance for Vaccines and Immunization"},{"ns":0,"exists":"","*":"Glucuronolactone"},{"ns":0,"exists":"","*":"Glycyrrhizin"},{"ns":0,"exists":"","*":"Government of the People's Republic of China"},{"ns":0,"exists":"","*":"Great Wall of China"},{"ns":0,"exists":"","*":"HBV vaccine"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"HIV/AIDS in China"},{"ns":0,"exists":"","*":"HIV/AIDS in the People's Republic of China"},{"ns":0,"exists":"","*":"Health care"},{"ns":0,"exists":"","*":"Health in China"},{"ns":0,"exists":"","*":"Health informatics in China"},{"ns":0,"exists":"","*":"Healthcare reform in China"},{"ns":0,"exists":"","*":"Hepatitis"},{"ns":0,"exists":"","*":"Hepatitis B"},{"ns":0,"exists":"","*":"Hepatitis B virus"},{"ns":0,"exists":"","*":"Hepatocellular carcinoma"},{"ns":0,"exists":"","*":"Horizontal transmission"},{"ns":0,"exists":"","*":"Hospitals"},{"ns":0,"exists":"","*":"Hospitals in China"},{"ns":0,"exists":"","*":"Human rights in China"},{"ns":0,"exists":"","*":"Illegal drug trade in China"},{"ns":0,"exists":"","*":"Immune response"},{"ns":0,"exists":"","*":"Immunization"},{"ns":0,"exists":"","*":"Infection"},{"ns":0,"exists":"","*":"Interferon alpha"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Iodine deficiency in China"},{"ns":0,"exists":"","*":"Jade Ribbon Campaign"},{"ns":0,"exists":"","*":"Kindergartens"},{"ns":0,"exists":"","*":"Kushenin"},{"ns":0,"exists":"","*":"Lamivudine"},{"ns":0,"exists":"","*":"Law of the People's Republic of China"},{"ns":0,"exists":"","*":"Leprosy in China"},{"ns":0,"exists":"","*":"Liver"},{"ns":0,"exists":"","*":"Liver cirrhosis"},{"ns":0,"exists":"","*":"Liver fibrosis"},{"ns":0,"exists":"","*":"Medicine"},{"ns":0,"exists":"","*":"Medicine in China"},{"ns":0,"exists":"","*":"Mental health in China"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Migrant labor"},{"ns":0,"exists":"","*":"Ministry (government department)"},{"ns":0,"exists":"","*":"Ministry of Health (China)"},{"ns":0,"exists":"","*":"Needle sharing"},{"ns":0,"exists":"","*":"Neonatal"},{"ns":0,"exists":"","*":"Nomadic"},{"ns":0,"exists":"","*":"Novartis AG"},{"ns":0,"exists":"","*":"Nucleotide analogues"},{"ns":0,"exists":"","*":"Obesity in China"},{"ns":0,"exists":"","*":"Organ transplantation in China"},{"ns":0,"exists":"","*":"PBS"},{"ns":0,"exists":"","*":"Patriotic Health Campaign"},{"ns":0,"exists":"","*":"Peasants"},{"ns":0,"exists":"","*":"Pediatrics"},{"ns":0,"exists":"","*":"Peginterferon alpha"},{"ns":0,"exists":"","*":"Pegylation"},{"ns":0,"exists":"","*":"People's Republic of China"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Pharmaceutical industry in China"},{"ns":0,"exists":"","*":"Pharmacy in China"},{"ns":0,"exists":"","*":"Pneumonic plague"},{"ns":0,"exists":"","*":"Pollution in China"},{"ns":0,"exists":"","*":"Polymorphism (biology)"},{"ns":0,"exists":"","*":"Porcine Reproductive and Respiratory Syndrome Virus"},{"ns":0,"exists":"","*":"Postnatal"},{"ns":0,"exists":"","*":"Poverty"},{"ns":0,"exists":"","*":"Poverty in China"},{"ns":0,"exists":"","*":"Prognosis"},{"ns":0,"exists":"","*":"Progress of the SARS outbreak"},{"ns":0,"exists":"","*":"Prospective cohort study"},{"ns":0,"exists":"","*":"Prostitution in China"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public health"},{"ns":0,"exists":"","*":"Public health in the People's Republic of China"},{"ns":0,"exists":"","*":"Regulation"},{"ns":0,"exists":"","*":"Relapse"},{"ns":0,"exists":"","*":"Retrospective cohort study"},{"ns":0,"exists":"","*":"Rural"},{"ns":0,"exists":"","*":"Sebivo"},{"ns":0,"exists":"","*":"Secretariat for Social Affairs and Culture (Macau)"},{"ns":0,"exists":"","*":"Severe acute respiratory syndrome"},{"ns":0,"exists":"","*":"Smoking in China"},{"ns":0,"exists":"","*":"Sophora flavescens"},{"ns":0,"exists":"","*":"State Administration of Traditional Chinese Medicine"},{"ns":0,"exists":"","*":"Stroke in China"},{"ns":0,"exists":"","*":"Switzerland"},{"ns":0,"exists":"","*":"Syringes"},{"ns":0,"exists":"","*":"Telbivudine"},{"ns":0,"exists":"","*":"The China Study"},{"ns":0,"exists":"","*":"Thymosin"},{"ns":0,"exists":"","*":"Traditional Chinese herbs"},{"ns":0,"exists":"","*":"Traditional Chinese medicine"},{"ns":0,"exists":"","*":"Traditional Chinese medicines"},{"ns":0,"exists":"","*":"Tuberculosis in China"},{"ns":0,"exists":"","*":"UNICEF"},{"ns":0,"exists":"","*":"US$"},{"ns":0,"exists":"","*":"Universities"},{"ns":0,"exists":"","*":"Urban area"},{"ns":0,"exists":"","*":"Vaccination"},{"ns":0,"exists":"","*":"Vegetarianism in China"},{"ns":0,"exists":"","*":"Violence against doctors in China"},{"ns":0,"exists":"","*":"Virus"},{"ns":0,"exists":"","*":"WHO"},{"ns":0,"exists":"","*":"Water supply and sanitation in China"},{"ns":0,"exists":"","*":"Women's health in China"},{"ns":0,"exists":"","*":"World Hepatitis Day"},{"ns":0,"exists":"","*":"Yi Nao"},{"ns":0,"exists":"","*":"\u019d"},{"ns":0,"*":"Idenix Pharmaceuticals"},{"ns":0,"*":"Viral suppression"},{"ns":0,"*":"Immunoprophylaxis"},{"ns":0,"*":"Diagnostic kit"},{"ns":0,"*":"National Health Commission"},{"ns":0,"*":"China Drug Administration"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Health in China"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Cn icon"},{"ns":10,"exists":"","*":"Template:Zh icon"},{"ns":10,"exists":"","*":"Template:Link language"},{"ns":10,"exists":"","*":"Template:ISO 639 name zh"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:En icon"},{"ns":10,"exists":"","*":"Template:ISO 639 name en"},{"ns":10,"exists":"","*":"Template:Health in the People's Republic of China"},{"ns":10,"exists":"","*":"Template:Health in China"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Link language"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Question_book-new.svg"],"externallinks":["https://web.archive.org/web/20091203232419/http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html","http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html","//doi.org/10.1097/00004836-200411003-00008","//www.ncbi.nlm.nih.gov/pubmed/15602165","//doi.org/10.1016/S0140-6736(07)60723-5","//www.ncbi.nlm.nih.gov/pubmed/16471211","//doi.org/10.1002/jmv.10094","//www.ncbi.nlm.nih.gov/pubmed/12116043","//www.ncbi.nlm.nih.gov/pubmed/15623388","http://www.jbjc.org/EN/abstract/abstract4350.shtml#","//doi.org/10.3784/j.issn.1003-9961.2004.8.290","//www.worldcat.org/issn/1003-9961","http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGJM200603020.htm","//www.worldcat.org/issn/1006-916X","https://link.springer.com/article/10.1007/s00038-011-0289-x","//doi.org/10.1007/s00038-011-0289-x","http://sm.stanford.edu/archive/stanmed/2008spring/safety_shot.html","//doi.org/10.1053/j.gastro.2005.03.009","//www.ncbi.nlm.nih.gov/pubmed/15940624","//doi.org/10.1056/NEJMe058119","//www.ncbi.nlm.nih.gov/pubmed/15987924","//doi.org/10.1016/S0140-6736(05)17701-0","//www.ncbi.nlm.nih.gov/pubmed/15639293","http://www.most.gov.cn/","https://web.archive.org/web/20100110134946/http://www.nsfc.gov.cn/nsfc2009/index.htm","http://www.nsfc.gov.cn/nsfc2009/index.htm","http://www.chinadaily.com.cn/english/doc/2005-01/21/content_411013.htm","https://www.pbs.org/newshour/updates/asia/july-dec11/china_10-06.html","http://english.cctv.com/program/chinatoday/20091230/101108.shtml","http://www.ft.com/cms/s/0/ca0e927c-4201-11dd-a5e8-0000779fd2ac.html","https://web.archive.org/web/20070614161359/http://www.chinacdc.net.cn/","http://www.who.int/countries/chn/en/","http://www.wpro.who.int/china","http://www.hbvhbv.com/","http://www.hbvhbv.com/english/"],"sections":[{"toclevel":1,"level":"2","line":"Epidemiology","number":"1","index":"1","fromtitle":"Hepatitis_B_in_China","byteoffset":1003,"anchor":"Epidemiology"},{"toclevel":2,"level":"3","line":"Prevalence","number":"1.1","index":"2","fromtitle":"Hepatitis_B_in_China","byteoffset":1021,"anchor":"Prevalence"},{"toclevel":2,"level":"3","line":"Transmission","number":"1.2","index":"3","fromtitle":"Hepatitis_B_in_China","byteoffset":4882,"anchor":"Transmission"},{"toclevel":1,"level":"2","line":"Programs","number":"2","index":"4","fromtitle":"Hepatitis_B_in_China","byteoffset":5285,"anchor":"Programs"},{"toclevel":2,"level":"3","line":"Public awareness","number":"2.1","index":"5","fromtitle":"Hepatitis_B_in_China","byteoffset":5299,"anchor":"Public_awareness"},{"toclevel":2,"level":"3","line":"Vaccination","number":"2.2","index":"6","fromtitle":"Hepatitis_B_in_China","byteoffset":5614,"anchor":"Vaccination"},{"toclevel":2,"level":"3","line":"Treatment","number":"2.3","index":"7","fromtitle":"Hepatitis_B_in_China","byteoffset":10138,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"Governmental intervention","number":"3","index":"8","fromtitle":"Hepatitis_B_in_China","byteoffset":14329,"anchor":"Governmental_intervention"},{"toclevel":2,"level":"3","line":"Problems","number":"3.1","index":"9","fromtitle":"Hepatitis_B_in_China","byteoffset":14360,"anchor":"Problems"},{"toclevel":2,"level":"3","line":"Research","number":"3.2","index":"10","fromtitle":"Hepatitis_B_in_China","byteoffset":17025,"anchor":"Research"},{"toclevel":2,"level":"3","line":"Progress","number":"3.3","index":"11","fromtitle":"Hepatitis_B_in_China","byteoffset":19108,"anchor":"Progress"},{"toclevel":1,"level":"2","line":"Social impact","number":"4","index":"12","fromtitle":"Hepatitis_B_in_China","byteoffset":20173,"anchor":"Social_impact"},{"toclevel":2,"level":"3","line":"Discrimination","number":"4.1","index":"13","fromtitle":"Hepatitis_B_in_China","byteoffset":20192,"anchor":"Discrimination"},{"toclevel":2,"level":"3","line":"\"In the Hepatitis B Camp\"","number":"4.2","index":"14","fromtitle":"Hepatitis_B_in_China","byteoffset":21956,"anchor":"\"In_the_Hepatitis_B_Camp\""},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"15","fromtitle":"Hepatitis_B_in_China","byteoffset":22926,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"16","fromtitle":"Hepatitis_B_in_China","byteoffset":23114,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"17","fromtitle":"Hepatitis_B_in_China","byteoffset":23156,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Hepatitis B in China","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q3144978"}]}}